We’re pleased to share the news that a group of scientists and business leaders from our Janssen team, along with a professor from the Harvard Business School, co-authored a new commentary in the February issue of the journal Nature Reviews Drug Discovery that addresses integrated approaches to healthcare solutions. Husseini Manji, Global Head of Neuroscience at Janssen Research & Development and Michael Yang, President of Janssen Pharmaceuticals, Inc. are two of the Janssen authors. The authors challenge the healthcare industry to expand its thinking beyond product-focused, "magic bullet" drug development and discuss the need for an integrated approach to patient care, including use of devices, tools and services to help a patient's progress. They discuss, for example, how people with serious mental illnesses, such as schizophrenia, are more likely to have better outcomes when they are involved in integrated care plans that involve more than a therapeutic and they look to a future when novel devices will help track and analyze patients’ progress. This commentary, "Beyond magic bullets: true innovation in health care," was published in the February 2013 issue of Nature Reviews Drug Discovery and is available here.
Janssen Scientists Challenge Industry to Create Integrated Approaches to Healthcare Innovation